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EMERGENCE OF SARS
quality of risk-communication of the
journalists or of the experts quoted in
the articles, wide press coverage of
the WHO global alert may have con-
tributed to public-health bodies’ tak-
ing action towards containing the epi-
demic.
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SARS-associated
Coronavirus
Infection in
Teenagers 
To the Editor: A global outbreak
of severe acute respiratory syndrome
(SARS) was reported in March 2003
(1). Most reported cases were in
adults. Hong Kong, however, reported
10 pediatric cases (2) with less
aggressive clinical courses. 
The disease became endemic in
Taiwan by the end of April 2003 (3).
Hualien City, a geographically seclud-
ed city in eastern Taiwan, had nine
pediatric cases, all mild. The cases
occurred in Tzu-Chi High School, a
private boarding school for 830 stu-
dents 12 to 18 years of age, all of
whom live in the same building and
eat daily meals together in the school
cafeteria. On April 28, when a student
(case-patient 1) visited the school
nurse on the first day that he had a
fever, an infection specialist from
affiliated Tzu-Chi Medical Center
immediately responded. The special-
ist discovered that this student’s close
friend in the same class (case-patient
2) was already febrile. Case-patient 2,
a Hong Kong resident who leaves
Taiwan for Hong Kong every 3
months, had visited Hong Kong twice
in March and April 2003. Both stu-
dents were isolated in the hospital on
April 28. 
Tzu-Chi Medical Center began a
search for other febrile students. On
April 29, seven more schoolmates
were found to have fever >38°C. All
were identified on their first day of
becoming febrile and were immedi-
ately isolated in the hospital. All nine
schoolmates underwent chest x-ray
examinations and were tested for
SARS-associated coronavirus (SARS
-CoV) by reverse transcription–poly-
merase chain reaction (RT-PCR) (4)
and DNA sequencing. The tested
length for SARS-CoV was 340 bp in
the RNA-dependent polymerase
region. Those teenagers with diarrhea
were tested for Norovirus in their
stool by RT-PCR. For those teenagers
with cough, throat swabs were cul-
tured for influenza and parainfluenza
virus. 
To reduce the risk for false-posi-
tive PCR results, we followed meas-
ures to avoid contamination during
specimen handling and processing.
Two primer sets were used for RT-
PCR according to Ksiazek (4) and
Drosten (5). The targets are located in
the RNA-dependent RNA polymerase
gene at different regions, which are
separated by approximately 3,000 bp.
The laboratory used in RT-PCR analy-
sis is not involved in viral culture or
extraction preparation and is located
far away from the laboratory for RNA
extraction to avoid contamination. 
Negative-control cDNA was in-
cluded in each analysis and confirmed
that no contamination had occurred.
Two operators manipulated RT-PCR
analysis for two specimens from the
same sample. The specimens were
analyzed in different rooms with inde-
pendent reagents for assurance. Real-
time RT-PCR instead of nested RT-
PCR was used. 
Six schoolmates were positive for
SARS-CoV by RT-PCR, confirmed
later by DNA sequencing for repli-
case. The tested DNA sequence was
>99% identical with a published
SARS-CoV sequence. Norovirus was
identified in one teenager’s stool by
RT-PCR; this virus belonged to
genogroup I by testing partial cDNA
sequence for capsid protein. The test-
ed length was 555 bp, and the virus
was 96% identical to strain KU4aGI.
Culture of a throat swab for influenza
and parainfluenza virus did not grow
any virus. 
The initial signs and symptoms of
the nine teenagers were self-reported
fever (9/9, range 37.8°C–39.4°C),
cough (4/9), general malaise (4/9),
diarrhea (4/9), rhinorrhea (3/9),
headache (2/9), chills (2/9), sore
throat (2/9), and myalgia (1/9). Cough
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was productive in three schoolmates
and dry in one. Chest x-ray results
were normal for eight teenagers but
showed linear interstitial pneumonia
for one teenager. Four schoolmates
took ribavirin for <2 days. Only the
teenager with pneumonia was treated
with both ribavirin and clar-
ithromycin, for 12 days. The other
four schoolmates did not take medica-
tion. All nine schoolmates became
afebrile by the third day. Seven
schoolmates were completely asymp-
tomatic in 3 days. Two other school-
mates showed improvement and had
normal values of all repeated labora-
tory tests in 5 days; however, they still
had mild coughs on the seventh day,
when they were discharged. The one
teenager with interstitial pneumonia
also had a normal chest x-ray result on
the fifth day. All nine teenagers were
discharged after 1 week of hospital-
ization and were continuously isolat-
ed in a special dormitory for another
2 weeks. No new cases of fever have
occurred in Tzu-Chi High School in
the 2 months since these patients’iso-
lation. 
Case-patient 2 was considered the
index patient for SARS-CoV infec-
tion because of his travel history to
Hong Kong. Six schoolmates with
fever were confirmed by real-time
RT-PCR and DNA sequences to have
SARS-CoV infection. For students
with diarrhea, only one case had coin-
fection with Norovirus. Influenza and
parainfluenza viral infection was
ruled out for students with cough.
Because the nine ill schoolmates were
isolated, no more cases of fever
occurred in the school. All epidemio-
logic, molecular, and clinical studies
showed evidence for SARS-CoV
infection.
Worldwide, SARS-CoV infection
has been clinically severe, character-
ized by respiratory distress and a 15%
average mortality rate (6–8). Reported
series of SARS with high mortality
rates have involved mainly adults.
Theoretically, subclinical or mild ill-
ness could be present and easily over-
looked, and thus death rates could be
overestimated.
The schoolmates in our series had
mild illnesses and were identified
only because of a special situation. On
May 7, 2003, the World Health
Organization (WHO) estimated that
the case-fatality rate for SARS ranged
from 0% to 50%, depending on the
age group affected (8); for teenagers
or younger children, the case-fatality
ratio was <1%. Our teenagers with
presumed SARS-CoV infection had
very mild courses. This benign course
was not related to treatment: only one
teenager had a full course of ribavirin
treatment, and most of the teenagers
had either no specific medications or
medications for <2 days. Our prelimi-
nary presumption for the benign
course was the patients’ young ages.
The benign course of SARS-CoV
infection in our teenage students sup-
ports the WHO finding of less-severe
disease in younger persons. These
reasons should be explored more fully
and may facilitate the development of
more effective treatment and preven-
tion programs in persons of all ages.
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